Literature DB >> 15489493

Neuro-ophthalmological disorders in HIV infected subjects with neurological manifestations.

J-C Mwanza1, L K Nyamabo, T Tylleskär, G T Plant.   

Abstract

AIMS: To determine the frequency and features of neuro-ophthalmological manifestations in neurologically symptomatic HIV infected patients and to assess whether or not the visual evoked potential (VEP) features in these patients differ from those of neurologically asymptomatic HIV infected patients.
METHODS: Neuro-ophthalmological evaluation was performed in 166 neurologically symptomatic confirmed HIV positive patients, of whom 75 with normal ophthalmological examination were further studied by means of VEPs. The VEPs values were compared to those obtained from 53 other confirmed HIV positive subjects with neither ophthalmological nor neurological manifestations, who served as a comparison group and to the references values of our laboratory.
RESULTS: An abnormal neuro-ophthalmological examination was noted in 99/166 patients (60%). Eye movement disorders were present in 99 patients (51%). Visual field defects were detected in 39% of the patients. Optic neuropathy was noted in 31%, papilloedema in 27% and ocular motor nerve palsies in 26% of the patients. Toxoplasmosis and cryptococcosis were the most frequent associated pathologies, though in some patients the HIV itself was the presumed cause. VEPs were abnormal in 57% and 42% of patients with and without neurological manifestations, respectively. Compared to asymptomatic patients, symptomatic patients had a significantly increased mean latency; however, both groups had significant increase in mean latency compared to reference values.
CONCLUSION: Neuro-ophthalmological manifestations are common in neurologically symptomatic HIV infected patients. Subclinical dysfunction in the visual pathways is a common phenomenon in both HIV infected patients with and without neurological symptoms, but neurologically symptomatic patients seem to have more damage in their visual pathways.

Entities:  

Mesh:

Year:  2004        PMID: 15489493      PMCID: PMC1772396          DOI: 10.1136/bjo.2004.044289

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  36 in total

1.  Eye movement abnormalities as a predictor of the acquired immunodeficiency syndrome dementia complex.

Authors:  J Currie; E Benson; B Ramsden; M Perdices; D Cooper
Journal:  Arch Neurol       Date:  1988-09

2.  Ophthalmic involvement in acquired immunodeficiency syndrome.

Authors:  A G Palestine; M M Rodrigues; A M Macher; C C Chan; H C Lane; A S Fauci; H Masur; D Longo; C M Reichert; R Steis
Journal:  Ophthalmology       Date:  1984-09       Impact factor: 12.079

3.  Disturbances in the cerebral perfusion of human immune deficiency virus-1 seropositive asymptomatic subjects: a quantitative tomography study of 18 cases.

Authors:  Y R Tran Dinh; H Mamo; J Cervoni; C Caulin; A C Saimot
Journal:  J Nucl Med       Date:  1990-10       Impact factor: 10.057

Review 4.  Neurologic complications of HIV infection.

Authors:  R M Levy; D E Bredesen; M L Rosenblum
Journal:  Am Fam Physician       Date:  1990-02       Impact factor: 3.292

5.  Neuro-ophthalmic findings in acquired immunodeficiency syndrome.

Authors:  A M Mansour
Journal:  J Clin Neuroophthalmol       Date:  1990-09

6.  Ocular manifestations of acquired immune deficiency syndrome.

Authors:  D A Jabs; W R Green; R Fox; B F Polk; J G Bartlett
Journal:  Ophthalmology       Date:  1989-07       Impact factor: 12.079

Review 7.  Neuro-ophthalmic manifestations of human immunodeficiency virus infection.

Authors:  D I Friedman
Journal:  Neurol Clin       Date:  1991-02       Impact factor: 3.806

8.  A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome.

Authors:  W R Freeman; C W Lerner; J A Mines; R S Lash; A J Nadel; M B Starr; M L Tapper
Journal:  Am J Ophthalmol       Date:  1984-02       Impact factor: 5.258

9.  Multimodal evoked potentials in HIV infected patients.

Authors:  G Farnarier; H Somma-Mauvais
Journal:  Electroencephalogr Clin Neurophysiol Suppl       Date:  1990

10.  Clinical and electrophysiological studies of human immunodeficiency virus-seropositive men without AIDS.

Authors:  T Smith; J Jakobsen; J Gaub; S Helweg-Larsen; W Trojaborg
Journal:  Ann Neurol       Date:  1988-03       Impact factor: 10.422

View more
  16 in total

1.  Reversible progressive supranuclear palsy-like phenotype as an initial manifestation of HIV infection.

Authors:  Wooyoung Jang; Joong-Seok Kim; Jin Young Ahn; Hee-Tae Kim
Journal:  Neurol Sci       Date:  2011-12-09       Impact factor: 3.307

2.  Pattern- and motion-related visual evoked potentials in HIV-infected adults.

Authors:  Jana Szanyi; Jan Kremlacek; Zuzana Kubova; Miroslav Kuba; Pavel Gebousky; Jaroslav Kapla; Juraj Szanyi; Frantisek Vit; Jana Langrova
Journal:  Doc Ophthalmol       Date:  2017-01-10       Impact factor: 2.379

3.  Acute kidney injury and inflammatory immune reconstitution syndrome in mixed genotype (A/E) hepatitis B virus co-infection in HIV-associated lymphoma.

Authors:  Katsushi Tajima; Kei Kohno; Yosuke Shiono; Ikuko Suzuki; Yuichi Kato; Yuki Hiroshima; Masakazu Yamamoto; Hiroya Ohtake; Akiko Iwaba; Mitsunori Yamakawa; Takeo Kato
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

4.  Longitudinal evaluation of resting-state connectivity, white matter integrity and cortical thickness in stable HIV infection: Preliminary results.

Authors:  Diogo G Corrêa; Nicolle Zimmermann; Nina Ventura; Gustavo Tukamoto; Thomas Doring; Sarah Cb Leite; Rochele P Fonseca; Paulo Rv Bahia; Fernanda Cr Lopes; Emerson L Gasparetto
Journal:  Neuroradiol J       Date:  2017-10-25

5.  Visual evoked and event-related brain potentials in HIV-infected adults: a longitudinal study over 2.5 years.

Authors:  Jana Szanyi; Jan Kremlacek; Zuzana Kubova; Miroslav Kuba; Pavel Gebousky; Jaroslav Kapla; Juraj Szanyi; Frantisek Vit; Jana Langrova
Journal:  Doc Ophthalmol       Date:  2019-04-16       Impact factor: 2.379

6.  The prevalence, clinical features, risk factors and outcome associated with cryptococcal meningitis in HIV positive patients in Kenya.

Authors:  R Mdodo; K Brown; E Omonge; W Jaoko; J Baddley; P Pappas; M Colette Kempf; I Aban; S Odera; A Suleh; P E Jolly
Journal:  East Afr Med J       Date:  2010-12

7.  Rhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentials.

Authors:  Mariam Riazi; Joanne K Marcario; Frank K Samson; Himanshu Kenjale; Istvan Adany; Vincent Staggs; Emily Ledford; Janet Marquis; Opendra Narayan; Paul D Cheney
Journal:  J Neuroimmune Pharmacol       Date:  2009-03-13       Impact factor: 4.147

8.  External ophthalmoplegia in human immunodeficiency virus-infected patients receiving antiretroviral therapy.

Authors:  Stacy L Pineles; Joseph L Demer; Gary N Holland; Susan S Ransome; Laura Bonelli; Federico G Velez
Journal:  J AAPOS       Date:  2012-11-14       Impact factor: 1.220

9.  Basic and translational neuro-ophthalmology of visually guided saccades: disorders of velocity.

Authors:  Sushant Puri; Aasef G Shaikh
Journal:  Expert Rev Ophthalmol       Date:  2017-11-28

10.  Vision recovery in human immunodeficiency virus-infected patients with optic neuropathy treated with highly active antiretroviral therapy: a case series.

Authors:  Kalpana Babu; Krishna R Murthy; Nirmala Rajagopalan; B Satish
Journal:  Indian J Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.